Sesamin is a lignan found in sesame seeds, and Japanese supplement makers have worked with it for decades, usually alongside vitamin E in an antioxidant-support formula. Brands abroad ask for a Japan-made sesamin product because of that long track record.

The track record is real, but the human evidence behind it is still modest — small trials, mixed results across different outcomes, and at least one notified benefit that held only in a subgroup of participants. This guide sets out what has actually been shown, and what a brand needs to decide before a Japan-made sesamin product, including the allergen question that sesame always raises.

Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.

💬 Planning a sesamin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.

What the human trials show

The clearest human trial of sesamin combined with vitamin E found a significant improvement in anti-oxidative capacity only in participants aged 40 and over, not in the group as a whole, and a separate meta-analysis found sesamin lowered cholesterol markers but not weight or triglycerides.

StudyDesignReported result
Placebo-controlled, double-blind, parallel-group trial, Global Journal of Health Science 2015 (PMID 26153159)111 healthy adults with feelings of daily fatigue analysed (of 309 enrolled), sesame lignans (sesamin and episesamin, 10 mg) plus vitamin E (about 55 mg alpha-tocopherol) versus placebo, 8 weeksSignificant improvements in subjective sleep and physical-appearance scores at 8 weeks; anti-oxidative capacity increased significantly versus placebo only in the subgroup aged 40 and over
Systematic review and meta-analysis, Frontiers in Endocrinology 2022 (PMID 35311241)7 randomised controlled trials, 212 participants, sesamin supplementationTotal cholesterol and LDL cholesterol fell significantly, and systolic blood pressure fell significantly; no significant effect on HDL cholesterol, triglycerides, diastolic blood pressure or body weight

The 2015 trial was designed and reported by the team that developed the test supplement, a point worth noting when weighing the strength of a “significant” result found in a subgroup rather than the full study population. The 2022 meta-analysis pooled a small number of trials with a modest combined sample size, and the authors’ own comparison shows sesamin’s effect is not uniform across outcomes: real for some lipid and blood-pressure markers, absent for others.

Checked against the published abstracts on 25 September 2026.

What Japanese products say

In Japan, sesamin combined with vitamin E is notified under the Foods with Function Claims system for a function described as raising antioxidant capacity and supporting the ease of falling asleep, depth of sleep and waking refreshed in people who feel everyday fatigue.

Under this system, the business that notifies the product submits its own evidence to the Consumer Affairs Agency before sale, and the wording stays close to what that evidence actually measured — antioxidant capacity and sleep-related wellbeing in people who already feel tired, not a claim about disease or ageing itself. A notification for one product’s specific formula and dose does not transfer to a different sesamin product.

💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from independent trial data? We prepare it with the manufacturing documents. Tell us your market.

Wording that stays on safe ground

Describe sesamin by the outcome actually studied, and be specific about which effects the evidence supports.

Safer wordingWording to avoid
”Contains sesamin and vitamin E, studied for antioxidant capacity""Anti-ageing” or “reverses ageing"
"Studied in adults with everyday fatigue”Disease names, or “treats” liver conditions
”May support healthy cholesterol already within a normal range” (only if your market allows it)Claims of cholesterol “treatment” or heart-disease prevention

How sesamin is formulated

Sesamin is usually paired with vitamin E and delivered as an oil-based capsule, because both are fat-soluble.

Dosage formWhy brands choose itWhat to weigh up
Softgel capsuleMatches sesamin’s oil solubility; the format used in the trials aboveOil oxidation over shelf life
Hard capsule with powder or oil blendCombines with other activesStability of the oil component

Decisions that shape the specification:

  1. Source. Sesamin is extracted from sesame oil or sesame seed; ask the supplier for the extraction method and sesamin/episesamin ratio.
  2. Companion vitamin E. Most studied formulas pair sesamin with vitamin E; specify the tocopherol source and amount, since this changes the product from sesamin alone.
  3. Allergen status. Sesame is one of the items Japan’s Consumer Affairs Agency recommends (though does not legally require) be declared on a food label, because of documented allergic reactions; declare it clearly regardless of your market’s own rules, since a sesamin-derived ingredient may still carry sesame allergen risk.
  4. Packaging and stability. Oil-based capsules need protection from heat, light and oxidation; agree the shelf-life testing this depends on.

The check that comes first

Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.

Sesamin and vitamin E used in foods are well established in Japan. The allergen declaration for sesame is a labelling question, not a food-law permission question, but it needs to be planned into your artwork from the start. See the Japan-made supplement OEM page, and compare with our vitamin E and coQ10 guides for two other antioxidant-linked ingredients.

Before you ask for a quotation

A factory can quote accurately once the sesamin amount, the vitamin E companion, the form and the packaging are fixed.

  • Sesamin amount per serving, and sesamin/episesamin ratio if specified
  • Vitamin E source and amount, if included
  • Dosage form and packaging
  • Allergen declaration approach for sesame
  • Countries you will sell in
  • First order and annual volume

💬 Ready to design a Japan-made sesamin product? Send us the concept — amount, vitamin E companion, form and the countries you will sell in.

Frequently asked questions

1. Is there strong evidence that sesamin fights ageing?
No. The clearest human trial found an antioxidant-capacity benefit only in participants aged 40 and over, not the full study group, and a meta-analysis found sesamin lowered some cholesterol markers and blood pressure but not weight or triglycerides. Describe sesamin as studied for specific markers, not as an anti-ageing ingredient.

2. Why is sesamin usually sold with vitamin E?
Because that is the combination used in the main human trial behind Japan’s notified antioxidant-capacity claim, and because both are fat-soluble and formulate well together in an oil-based capsule.

3. Does sesamin need an allergen warning?
Sesame is one of the items Japan’s Consumer Affairs Agency recommends declaring on food labels because of documented allergic reactions, even though it is not on the shorter list of legally mandatory items. Declare it on your label regardless of your own market’s specific rules.

4. What dosage form suits sesamin best?
A softgel or oil-filled capsule, since sesamin and its usual companion vitamin E are both fat-soluble and this is the form used in the published trials.

5. What can stop a Japanese factory making my sesamin product?
Usually a companion ingredient in a “healthy ageing” formula that Japan treats as a medicine rather than a food. Every ingredient must be permitted in foods in Japan, so we check the full formula first.


Sources: “Sesame Lignans and Vitamin E Supplementation Improve Subjective Statuses and Anti-Oxidative Capacity in Healthy Humans With Feelings of Daily Fatigue”, Global Journal of Health Science 2015 (PMID 26153159); “The Effects of Sesamin Supplementation on Obesity, Blood Pressure, and Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”, Frontiers in Endocrinology 2022 (PMID 35311241); Consumer Affairs Agency notifications for Foods with Function Claims; Consumer Affairs Agency guidance on recommended allergen labelling items. Checked on 25 September 2026.